<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">jmir</journal-id><journal-id journal-id-type="index">1</journal-id><journal-title>Journal of Medical Internet Research</journal-title><abbrev-journal-title>J Med Internet Res</abbrev-journal-title><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v28i1e104883</article-id><article-id pub-id-type="doi">10.2196/104883</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Digital Behavioral Risk Stratification Tool Integrated With HIV Online Self-Testing for HIV Positivity Among Men Who Have Sex With Men: Retrospective Observational Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names>Wencheng</given-names></name><degrees>BM</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Yan</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zhang</surname><given-names>Guanbin</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Lv</surname><given-names>Yi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib></contrib-group><aff id="aff1"><institution>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</institution><addr-line>155 Changbai Road, Changping District</addr-line><addr-line>Beijing</addr-line><country>China</country></aff><aff id="aff2"><institution>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases</institution><addr-line>Beijing</addr-line><country>China</country></aff><aff id="aff3"><institution>Chinese Association of STD and AIDS Prevention and Control</institution><addr-line>Beijing</addr-line><country>China</country></aff><aff id="aff4"><institution>School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine</institution><addr-line>Chengdu</addr-line><country>China</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mavragani</surname><given-names>Amaryllis</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Ershadmanesh</surname><given-names>Mohamadjavad</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Liu</surname><given-names>Zhao</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Yi Lv, PhD, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, China, 86 18001131913; <email>yilv@chinaaids.cn</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>11</day><month>11</month><year>2026</year></pub-date><volume>28</volume><elocation-id>e104883</elocation-id><history><date date-type="received"><day>17</day><month>06</month><year>2026</year></date><date date-type="rev-recd"><day>04</day><month>09</month><year>2026</year></date><date date-type="accepted"><day>07</day><month>10</month><year>2026</year></date></history><copyright-statement>&#x00A9; Wencheng Liu, Yan Jiang, Guanbin Zhang, Yi Lv. Originally published in the Journal of Medical Internet Research (<ext-link ext-link-type="uri" xlink:href="https://www.jmir.org">https://www.jmir.org</ext-link>), 11.11.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://www.jmir.org/">https://www.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://www.jmir.org/2026/1/e104883"/><abstract><sec><title>Background</title><p>Due to concerns about privacy breaches and the fear of social stigma, some individuals engaging in high-risk behaviors&#x2014;particularly men who have sex with men (MSM)&#x2014;may avoid in-person HIV testing services and instead choose to purchase HIV self-test kits online. Unlike traditional e-commerce platforms that provide self-test kits directly without conducting risk assessments, the &#x201C;Easy Test Know&#x201D; platform integrates a structured behavioral risk assessment prior to purchasing an HIV self-test kit, allowing users to be categorized into different HIV risk groups.</p></sec><sec><title>Objective</title><p>This study aimed to evaluate the performance of a digital HIV behavioral risk stratification tool integrated with online self-testing among MSM and to determine whether incorporating multidimensional behavioral indicators&#x2014;particularly the high-risk venue diversity score&#x2014;could improve the prediction of HIV positivity compared with the platform&#x2019;s existing rule-based risk-scoring algorithm.</p></sec><sec sec-type="methods"><title>Methods</title><p>This retrospective observational study used data from the &#x201C;Easy Test Know&#x201D; platform between November 2023 and February 2025. The analysis included 9961 MSM classified as medium or high risk who had a usable HIV test result. The continuous platform score and the deployed categorical output were evaluated, and enhanced and fully adjusted Firth logistic regression models were compared using areas under the receiver operating characteristic curves (AUCs) with stratified bootstrap 95% CIs, DeLong tests, calibration measures, and bootstrap optimism correction based on 1000 successful model refits.</p></sec><sec sec-type="results"><title>Results</title><p>Among 9961 participants, 9044 (90.8%) were classified as high risk, and 58 (0.58%) had an observed HIV-positive result. Positivity was 0.6% (n=54) in the high-risk group and 0.4% (4/914) in the medium-risk group, but the difference was not statistically significant (<italic>P</italic>=.70). The deployed categorical output had an AUC of 0.512 (95% CI 0.477&#x2010;0.539), with 93.1% (54/58) sensitivity and 9.2% (913/9903) specificity, whereas the continuous platform score had an AUC of 0.646 (95% CI 0.567&#x2010;0.725). Each 1-category increase in high-risk venue diversity was associated with higher odds of observed HIV positivity (odds ratio 2.04, 95% CI 1.53&#x2010;2.74; <italic>P</italic> for trend &#x003C;.001). The enhanced and fully adjusted models had apparent AUCs of 0.728 (95% CI 0.656&#x2010;0.801) and 0.752 (95% CI 0.686&#x2010;0.817) and optimism-corrected AUCs of 0.688 and 0.713, respectively. Their optimism-corrected calibration slopes were 0.940 and 0.936.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Compared with the platform&#x2019;s original rule-based scoring system, the data-driven behavioral models incorporating high-risk venue diversity showed improved predictive performance, although bootstrap optimism correction yielded more conservative estimates. These findings support further development and independent validation of data-driven approaches to optimize digital HIV risk assessment tools.</p></sec></abstract><kwd-group><kwd>HIV self-testing</kwd><kwd>men who have sex with men</kwd><kwd>digital health</kwd><kwd>risk stratification</kwd><kwd>public health interventions</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Due to concerns about privacy breaches and social stigma, some high-risk individuals, especially men who have sex with men (MSM), may avoid offline HIV testing services and instead seek online HIV self-testing (HIVST) services [<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref4">4</xref>]. Online HIVST offers a private and accessible complement to conventional testing and may reach individuals who are less likely to use in-person services [<xref ref-type="bibr" rid="ref5">5</xref>-<xref ref-type="bibr" rid="ref7">7</xref>]. Recent digitally supported and web-based HIVST programs have also demonstrated opportunities to connect self-testing with counseling, prevention, and linkage to care [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>].</p><p>The &#x201C;Easy Test Know&#x201D; (Beijing Association for the Prevention and Control of Sexually Transmitted Diseases and AIDS) platform incorporates an HIV risk assessment module based on a structured behavioral questionnaire before users purchase HIVST kits, allowing users to be categorized into different HIV risk groups. This integrated approach combines digital behavioral assessment with online HIVST services and may provide a practical framework for targeted HIV prevention and testing interventions [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>].</p><p>Previous studies on online HIVST have primarily examined acceptability, uptake, service delivery, or individual behavioral risk factors [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>]. Existing HIV prediction studies have applied regression or machine learning approaches to behavioral data [<xref ref-type="bibr" rid="ref14">14</xref>-<xref ref-type="bibr" rid="ref16">16</xref>], but limited evidence is available for model development and internal validation within routine online HIVST services or for direct comparisons with deployed rule-based scores. Less is known about whether pretest digital risk scores correspond to observed HIV testing outcomes in routine service settings. Outcome-based evaluation is particularly important because expert-assigned weights and final risk categories may not preserve all the predictive information contained in the underlying behavioral data.</p><p>In addition, many existing HIV risk assessment approaches rely on isolated behavioral indicators and may not adequately capture cumulative exposure across multiple high-risk contexts. Individuals reporting exposure to multiple high-risk venues may engage in more complex behavioral patterns and broader social or sexual environments, potentially increasing HIV transmission risk [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]. Therefore, composite indicators reflecting multidimensional behavioral exposure may provide additional value for digital HIV risk prediction.</p><p>Using real-world data from the &#x201C;Easy Test Know&#x201D; platform, this study examined demographic and behavioral characteristics among MSM purchasing HIVST kits online. We further evaluated the association between the high-risk venue diversity score and HIV positivity and assessed whether behavioral reconstruction models could improve HIV risk prediction compared with the platform&#x2019;s original rule-based scoring algorithm. Compared with previous studies, this study makes several notable contributions: (1) it is among the first real-world studies to systematically evaluate the consistency between digital HIV risk stratification and actual HIV positivity outcomes among MSM purchasing HIVST kits online; (2) it provides novel evidence on the association between the high-risk venue diversity score and HIV infection risk, including its dose-response relationship; and (3) it offers a comparative evaluation between the platform&#x2019;s original rule-based composite scoring system and a data-driven behavioral modeling strategy constructed from the original behavioral variables, providing practical evidence for the optimization of digital HIV risk stratification tools.</p><p>Accordingly, the study evaluated the fixed platform score and deployed risk categories and developed 2 outcome-driven behavioral prediction models with bootstrap internal validation; no external validation data set was used.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design and Data Source</title><p>This retrospective observational prediction model development and internal validation study used real-world data from the &#x201C;Easy Test Know&#x201D; online HIVST platform. Demographic, transaction, and behavioral data were collected from November 2023 to February 2025. The study was conducted through a single digital service platform serving users across China; because recruitment and data collection occurred online, no physical recruitment centers were involved. The platform integrates a structured HIV risk assessment questionnaire (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>). Based on questionnaire responses, users were classified into low-, medium-, or high-risk categories.</p></sec><sec id="s2-2"><title>Recruitment and Data Collection</title><p>Recruitment occurred through the platform&#x2019;s routine service pathway rather than a study-specific campaign. Users voluntarily accessed the service, and no additional participants were recruited, contacted, or assigned to an exposure by the research team. Records generated during routine use were screened against prespecified eligibility criteria for this retrospective secondary analysis.</p></sec><sec id="s2-3"><title>Study Population</title><p>The study population consisted of MSM who completed the platform-based HIV risk assessment and purchased HIVST kits. Participants were included if they were classified as medium or high risk, completed the HIVST pathway, and had an available, usable HIV test result recorded in the platform database. Purchasers without an available or usable test result were excluded rather than being classified as HIV-negative. Low-risk users generally did not proceed to kit purchase and therefore lacked an observed testing outcome within the platform; consequently, they could not be included in outcome-based predictive analyses. MSM eligibility was based on reported male-to-male sexual behavior rather than self-identified sexual orientation.</p></sec><sec id="s2-4"><title>Platform-Based HIV Risk Scoring Algorithm</title><p>The platform employs a rule-based HIV risk scoring algorithm (<xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>) that assigns weighted scores based on demographic characteristics and HIV-related behavioral factors. Users are subsequently categorized into low-, medium-, or high-risk groups according to their final scores. The deployed platform calculated the dimension 1 and 2 base scores and applied its configured dimension 3 combination rules before storing the final continuous score and categorical output. The present study used these stored final outputs without modifying or recalculating the platform&#x2019;s algorithm. The reconstructed Firth regression models were developed independently of the individual behavioral variables and did not reapply the platform&#x2019;s dimension 3 rules.</p></sec><sec id="s2-5"><title>Firth Logistic Regression</title><p>The study used Firth logistic regression to address potential biases that may arise in standard logistic regression. Because HIV-positive outcomes were relatively rare in the study population, Firth logistic regression was used to reduce rare-event bias in parameter estimation and to provide finite estimates under complete or quasi-complete separation. This was relevant because only 58 HIV-positive outcomes were observed, and no HIV-positive outcomes occurred among participants reporting pre-exposure prophylaxis (PrEP) use. The fully adjusted model contained 24 predictor parameters (events-per-variable ratio, 2.42). Firth penalization was therefore used to support finite, less biased coefficient estimation in this rare-event setting.</p></sec><sec id="s2-6"><title>Behavioral Variables and High-Risk Exposure</title><p>The platform-based questionnaire collected information on HIV-related demographic and behavioral factors, including sexual orientation, condom use, HIV-positive partner status, number of sexual partners, commercial sex, history of sexually transmitted infections, use of new psychoactive drugs, sexual role, and group sex. The analytical dataset also contained recorded use of PrEP and postexposure prophylaxis (PEP), which were analyzed as separate variables. PEP and PrEP were recorded separately and were not components of the platform&#x2019;s original scoring algorithm.</p><p>Sexual orientation was analyzed as a demographic characteristic distinct from the behavioral definition of MSM. The drug-use item asked whether participants had used new psychoactive drugs but did not capture specific substances, frequency, dose, or recency. The original partner-number response options were 2 to 5, 6 to 9, and greater than 10; the questionnaire did not provide categories for zero or one partner and left exactly 10 partners unspecified.</p><p>High-risk exposure was assessed based on 6 predefined location categories, including mobile social networking applications, online dating platforms, parks, bathhouses, public toilets, and bars/clubs. Because participants could report exposure to multiple venues, we constructed a composite indicator termed the high-risk venue diversity score, defined as the number of different high-risk venues reported by each participant (range: 0&#x2010;6). This indicator was intended to reflect cumulative exposure across multiple high-risk contexts [<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>]. &#x201C;Only regular sexual partners&#x201D; represented zero exposure and was not counted as an additional venue. Although &#x201C;sex work venues&#x201D; appeared in the questionnaire, no participant selected this option in the analytical dataset. This derived measure was distinct from the platform&#x2019;s original weighted scoring algorithm.</p></sec><sec id="s2-7"><title>Outcome Measures</title><p>The primary outcome was HIV-positive status, defined as a participant-reported positive HIVST result submitted through the platform or a positive result from offline HIV testing reported after completion of the platform-based risk assessment. The outcome was taken directly from the recorded participant report, and no separate blinded outcome adjudication was performed. Participants without a usable returned result were excluded from the analytical dataset; therefore, the observed positivity proportion should not be interpreted as HIV prevalence among all platform purchasers or the broader MSM population.</p></sec><sec id="s2-8"><title>Study Size and Missing Data</title><p>The study size was determined pragmatically by all eligible records available in the supplied routine-service extract during the prespecified study period; no a priori sample size calculation was performed. Of 10,058 records screened, 87 records from female users were excluded, leaving 9971 male users meeting the platform-based MSM definition. Ten users without a usable self-reported HIVST or offline HIV test result were then excluded, resulting in the analytical sample of 9961; the usable-result return rate in this MSM pathway was therefore 99.9% (9961/9971), and 0.1% (10/9971) lacked a usable result. There were no missing values for the outcome or candidate model predictors in the analytical dataset; all model analyses used the same complete dataset, and no imputation was performed.</p></sec><sec id="s2-9"><title>Statistical Analysis</title><p>Categorical variables are presented as counts and percentages. Comparisons between medium- and high-risk groups and between the observed HIV-negative and HIV-positive groups were performed using chi-square or Fisher exact tests, as appropriate. The complete high-risk venue diversity score (0-6) was additionally evaluated for linear trend using Firth logistic regression, with the score treated as an ordinal continuous variable.</p><p>To evaluate HIV risk prediction performance, we constructed and compared three model specifications: (1) a baseline model that contained only the continuous platform risk scores; (2) an enhanced behavioral model that additionally incorporated the high-risk venue diversity scores; and (3) a fully adjusted behavioral model that incorporated additional HIV-related behavioral variables.</p><p>Because several behavioral variables had already been incorporated into the platform&#x2019;s original scoring algorithm, the reconstructed models primarily evaluated whether data-driven weighting of behavioral information could improve predictive performance rather than the addition of entirely new predictors. The platform&#x2019;s deployed categorical risk output was evaluated separately as an operational comparator.</p><p>The continuous platform score was modeled as a linear term. Age and all questionnaire-derived predictors were modeled using the predefined categories described in the <italic>Result</italic> section and <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>. In the reconstructed models, high-risk venue diversity was entered as 0, 1, or &#x2265;2 venues; in a separate trend analysis, the complete score (0-6) was entered as an ordinal continuous variable. The same 9961 complete records were used in all model analyses.</p><p>Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC), and DeLong tests were used to compare AUCs between models. Stratified bootstrap resampling (2000 replicates) was used to estimate 95% CIs for apparent AUCs. Internal validation of the enhanced and fully adjusted Firth models used stratified bootstrap optimism correction. In each resample, the complete model was refitted in the bootstrap sample and evaluated in both the bootstrap sample and the original data; mean optimism was calculated as bootstrap-sample performance minus original-sample performance and subtracted from the apparent estimate. Sampling continued until 1000 successful refits were obtained for each model, and unsuccessful attempts were recorded. Optimism correction was applied to the AUC, calibration-in-the-large, calibration slope, expected-to-observed (E/O) ratio on the log scale, and Brier score. Hosmer-Lemeshow statistics were reported only for apparent calibration. Calibration plots display apparent and bootstrap bias-corrected curves based on 1000 resamples. The number of outcome events per estimated predictor parameter was calculated for each reconstructed model. All analyses were conducted using R software (version 4.5.2; R Foundation for Statistical Computing), and a 2-sided <italic>P</italic> value &#x003C;.05 was considered statistically significant.</p></sec><sec id="s2-10"><title>Ethical Considerations</title><p>This study was approved by the Ethics Review Committee of the National Center for AIDS/Sexually Transmitted Disease Control and Prevention, Chinese Center for Disease Control and Prevention (approval number X131022302). The analytical dataset was deidentified before analysis and was accessible only to authorized study personnel; privacy and confidentiality were maintained throughout data handling and analysis. Participants received no additional compensation specifically for this retrospective secondary analysis. All study procedures were conducted in accordance with relevant guidelines and regulations.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Analysis of Participant Characteristics and HIV Positivity</title><p>Of the 10,058 records in the supplied routine-service extract, 87 records from female users and 10 records from male users without a usable HIV test result were excluded. Among 9971 male users meeting the platform-based MSM definition, 9961 (99.9%) had a usable returned result. The final analysis included these 9961 MSM (<xref ref-type="table" rid="table1">Table 1</xref>), including 917 (9.2%) classified as medium risk and 9044 (90.8%) classified as high risk by the platform algorithm. Of these participants, 58 had an observed HIV-positive result and 9903 had an observed HIV-negative result.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Participant characteristics by platform-assigned risk category among 9961 medium- and high-risk men who have sex with men (MSM), Easy Test Know online HIV self-testing platform, China, November 2023 to February 2025.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Variables</td><td align="left" valign="bottom">Medium risk<break/>(n=917)</td><td align="left" valign="bottom">High risk<break/>(n=9044)</td><td align="left" valign="bottom"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="3">Age (y), n (%)</td><td align="left" valign="top">&#x003C;.001<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003C;20</td><td align="left" valign="top">8 (0.9)</td><td align="left" valign="top">226 (2.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>20</td><td align="left" valign="top">76 (8.3)</td><td align="left" valign="top">1755 (19.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>30</td><td align="left" valign="top">671 (73.2)</td><td align="left" valign="top">6064 (67.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>40</td><td align="left" valign="top">135 (14.7)</td><td align="left" valign="top">808 (8.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>50</td><td align="left" valign="top">10 (1.1)</td><td align="left" valign="top">108 (1.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60</td><td align="left" valign="top">17 (1.9)</td><td align="left" valign="top">83 (0.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Sexual orientation, n (%)</td><td align="left" valign="top">.83</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Uncertain</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">1 (0.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Bisexual</td><td align="left" valign="top">10 (1.1)</td><td align="left" valign="top">83 (0.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Homosexual</td><td align="left" valign="top">907 (98.9)</td><td align="left" valign="top">8960 (99.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Sexual role, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Both</td><td align="left" valign="top">55 (5.9)</td><td align="left" valign="top">1189 (13.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Receptive</td><td align="left" valign="top">96 (10.5)</td><td align="left" valign="top">4334 (47.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Insertive</td><td align="left" valign="top">766 (83.5)</td><td align="left" valign="top">3521 (38.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">High-risk venue category<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup>, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>0</td><td align="left" valign="top">2 (0.2)</td><td align="left" valign="top">1 (0.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>1</td><td align="left" valign="top">614 (66.9)</td><td align="left" valign="top">2134 (23.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x2265;2</td><td align="left" valign="top">301 (32.8)</td><td align="left" valign="top">6909 (76.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Condom use, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Consistent use</td><td align="left" valign="top">14 (1.5)</td><td align="left" valign="top">12 (0.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Occasional use</td><td align="left" valign="top">896 (97.7)</td><td align="left" valign="top">7631 (84.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No use</td><td align="left" valign="top">7 (0.8)</td><td align="left" valign="top">1401 (15.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">HIV-positive partner, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top">&#x2003;Uncertain</td><td align="left" valign="top">836 (91.2)</td><td align="left" valign="top">8779 (97.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">81 (8.8)</td><td align="left" valign="top">264 (2.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">1 (0.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Number of partners, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003E;10</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">8 (0.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>2&#x2010;5</td><td align="left" valign="top">911 (99.3)</td><td align="left" valign="top">7818 (86.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>6&#x2010;9</td><td align="left" valign="top">6 (0.7)</td><td align="left" valign="top">1218 (13.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Commercial sex, n (%)</td><td align="left" valign="top">.01</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">917 (100)</td><td align="left" valign="top">8974 (99.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">70 (0.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Group sex, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Uncertain</td><td align="left" valign="top">3 (0.3)</td><td align="left" valign="top">197 (2.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">887 (96.7)</td><td align="left" valign="top">8254 (91.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Occasional</td><td align="left" valign="top">27 (2.9)</td><td align="left" valign="top">593 (6.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">STI<sup><xref ref-type="table-fn" rid="table1fn3">c</xref></sup> history, n (%)</td><td align="left" valign="top">.65</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">917 (100)</td><td align="left" valign="top">9034 (99.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">10 (0.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">New psychoactive drug use, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">509 (55.5)</td><td align="left" valign="top">841 (9.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">408 (44.5)</td><td align="left" valign="top">8203 (90.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">PEP<sup><xref ref-type="table-fn" rid="table1fn4">d</xref></sup> use, n (%)</td><td align="left" valign="top">.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">915 (99.8)</td><td align="left" valign="top">9044 (100)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">2 (0.2)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">PrEP<sup><xref ref-type="table-fn" rid="table1fn5">e</xref></sup> use, n (%)</td><td align="left" valign="top">.70</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">836 (91.2)</td><td align="left" valign="top">8205 (90.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">81 (8.8)</td><td align="left" valign="top">839 (9.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">HIV-positive, n (%)</td><td align="left" valign="top">.70</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">913 (99.6)</td><td align="left" valign="top">8990 (99.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">4 (0.4)</td><td align="left" valign="top">54 (0.6)</td><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup><italic>P</italic> values were calculated using chi-square tests or Fisher exact tests, as appropriate.</p></fn><fn id="table1fn2"><p><sup>b</sup>High-risk venue diversity score was categorized based on the number of reported high-risk venue types.</p></fn><fn id="table1fn3"><p><sup>c</sup>STI: sexually transmitted infection.</p></fn><fn id="table1fn4"><p><sup>d</sup>PEP: postexposure prophylaxis.</p></fn><fn id="table1fn5"><p><sup>e</sup>PrEP: pre-exposure prophylaxis.</p></fn></table-wrap-foot></table-wrap><p>Compared with participants in the medium-risk group, those classified as high risk differed across multiple behavioral characteristics, including sexual role, high-risk venue diversity, condom use, HIV-positive partner status, number of sexual partners, commercial sex, group sex, drug use, and PEP use (<xref ref-type="table" rid="table1">Table 1</xref>). These differences describe how the rule-based platform score stratified behavioral profiles.</p><p>The distribution of high-risk venue exposure differed substantially between groups. Participants in the high-risk group were considerably more likely to report exposure to 2 or more high-risk venues compared with those in the medium-risk group (6909/9044, 76.4% vs 301/917, 32.8%; <italic>P</italic>&#x003C;.001), indicating substantial differences in cumulative behavioral exposure patterns between the 2 risk categories.</p><p>Among the 9961 participants, 58 had an observed positive HIV test result, corresponding to an observed positivity proportion of 0.58% (<xref ref-type="table" rid="table2">Table 2</xref>). Participants classified as high risk had a numerically higher positivity proportion than those classified as medium risk (54/9044, 0.6% vs 4/917, 0.4%), but the difference was not statistically significant. The observed positivity proportion reflects only participants with available test results and should not be interpreted as HIV prevalence among all platform users or the broader MSM population.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Participant characteristics by observed HIV test result among 9961 medium- and high-risk men who have sex with men (MSM), Easy Test Know online HIV self-testing platform, China, November 2023 to February 2025.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Variables</td><td align="left" valign="bottom">Negative<break/>(n=9903)</td><td align="left" valign="bottom">Positive<break/>(n=58)</td><td align="left" valign="bottom"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="3">Age (y), n (%)</td><td align="left" valign="top">.048</td></tr><tr><td align="left" valign="top">&#x2003;&#x003C;20</td><td align="left" valign="top">234 (2.4)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>20</td><td align="left" valign="top">1815 (18.3)</td><td align="left" valign="top">16 (27.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>30</td><td align="left" valign="top">6704 (67.7)</td><td align="left" valign="top">31 (53.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>40</td><td align="left" valign="top">934 (9.4)</td><td align="left" valign="top">9 (15.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>50</td><td align="left" valign="top">116 (1.2)</td><td align="left" valign="top">2 (3.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60</td><td align="left" valign="top">100 (1.0)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Sexual orientation, n (%)</td><td align="left" valign="top">.76</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Uncertain</td><td align="left" valign="top">1 (0.0)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Bisexual</td><td align="left" valign="top">93 (0.9)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Homosexual</td><td align="left" valign="top">9809 (99.1)</td><td align="left" valign="top">58 (100)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Sexual role, n (%)</td><td align="left" valign="top">.39</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Both</td><td align="left" valign="top">1238 (12.5)</td><td align="left" valign="top">6 (10.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Receptive</td><td align="left" valign="top">4399 (44.4)</td><td align="left" valign="top">31 (53.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Insertive</td><td align="left" valign="top">4266 (43.1)</td><td align="left" valign="top">21 (36.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Platform risk level, n (%)</td><td align="left" valign="top">.70</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Medium risk</td><td align="left" valign="top">913 (9.2)</td><td align="left" valign="top">4 (6.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>High risk</td><td align="left" valign="top">8990 (90.8)</td><td align="left" valign="top">54 (93.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">High-risk venue category, n (%)</td><td align="left" valign="top">.01</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>0</td><td align="left" valign="top">3 (0.0)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>1</td><td align="left" valign="top">2742 (27.7)</td><td align="left" valign="top">6 (10.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x2265;2</td><td align="left" valign="top">7158 (72.3)</td><td align="left" valign="top">52 (89.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Condom use, n (%)</td><td align="left" valign="top">.33</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Consistent use</td><td align="left" valign="top">26 (0.3)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Occasional use</td><td align="left" valign="top">8481 (85.6)</td><td align="left" valign="top">46 (79.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No use</td><td align="left" valign="top">1396 (14.1)</td><td align="left" valign="top">12 (20.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">HIV-positive partner, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top">&#x2003;Uncertain</td><td align="left" valign="top">9571 (96.6)</td><td align="left" valign="top">44 (75.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">332 (3.4)</td><td align="left" valign="top">13 (22.4)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">1 (1.7)</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top" colspan="3">Number of partners, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003E;10</td><td align="left" valign="top">4 (0.0)</td><td align="left" valign="top">4 (6.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>2&#x2010;5</td><td align="left" valign="top">8688 (87.7)</td><td align="left" valign="top">41 (70.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>6&#x2010;9</td><td align="left" valign="top">1211 (12.2)</td><td align="left" valign="top">13 (22.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Commercial sex (%)</td><td align="left" valign="top">.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">9836 (99.3)</td><td align="left" valign="top">55 (94.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">67 (0.7)</td><td align="left" valign="top">3 (5.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">Group sex, n (%)</td><td align="left" valign="top">.008</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Uncertain</td><td align="left" valign="top">200 (2.0)</td><td align="left" valign="top">0 (0.0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">9092 (91.8)</td><td align="left" valign="top">49 (84.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Occasional</td><td align="left" valign="top">611 (6.2)</td><td align="left" valign="top">9 (15.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">STI<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup> history, n (%)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">9897 (99.9)</td><td align="left" valign="top">54 (93.1)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">6 (0.1)</td><td align="left" valign="top">4 (6.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">New psychoactive drug use, n (%)</td><td align="left" valign="top">&#x003E;.99</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">1342 (13.6)</td><td align="left" valign="top">8 (13.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">8561 (86.4)</td><td align="left" valign="top">50 (86.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">PEP<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup> use, n (%)</td><td align="left" valign="top">&#x003E;.99</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">9901 (99.9)</td><td align="left" valign="top">58 (100)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">2 (0.0)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="3">PrEP<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup> use, n (%)</td><td align="left" valign="top">.03</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">8983 (90.7)</td><td align="left" valign="top">58 (100)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">920 (9.3)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>STI: sexually transmitted infection.</p></fn><fn id="table2fn2"><p><sup>b</sup>PEP: postexposure prophylaxis.</p></fn><fn id="table2fn3"><p><sup>c</sup>PrEP: pre-exposure prophylaxis.</p></fn></table-wrap-foot></table-wrap><p>The continuous platform risk score showed modest discrimination for observed HIV positivity (AUC 0.646, 95% CI 0.567&#x2010;0.725; Table S1 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). When the deployed categorical risk output was evaluated directly, its AUC was 0.512 (95% CI 0.477&#x2010;0.539). The categorical output achieved high sensitivity (93.1%), classifying 54 of 58 HIV-positive participants as high risk, although its specificity was 9.2% (913/9903); the remaining 4 HIV-positive participants were classified as medium risk.</p><p>Observed HIV positivity increased across the well-populated levels of the high-risk venue diversity score: 0% (0/3) at score 0, 0.2% (6/2748) at score 1, 0.5% (18/3824) at score 2, 0.8% (21/2762) at score 3, and 2.1% (13/623) at score 4; only one participant had a score of 5, and none had a score of 6 (Table S4 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). In Firth logistic regression, each 1-category increase in the diversity score was associated with higher odds of observed HIV positivity (odds ratio [OR] 2.04, 95% CI 1.53&#x2010;2.74; <italic>P</italic> for trend &#x003C;.001).</p><p>HIV-positive partner status was strongly associated with observed HIV positivity in the fully adjusted model (<xref ref-type="table" rid="table3">Table 3</xref>), although estimates were imprecise for the very small &#x201C;yes&#x201D; group. Compared with participants who were uncertain about their partner&#x2019;s HIV status, the adjusted OR was 6.57 (95% CI 2.87&#x2010;13.58) for those reporting no HIV-positive partner and 172.22 (95% CI 7.76&#x2010;27,046.77) for those reporting an HIV-positive partner. PrEP use was inversely associated with observed HIV positivity: none of the 920 PrEP users had a positive result, compared with 58 positive results among 9041 nonusers (adjusted OR 0.10, 95% CI 0.001&#x2010;0.68; <italic>P</italic>=.01). This complete separation was one rationale for the use of Firth regression and should not be interpreted as a causal estimate of PrEP effectiveness.</p><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Fully adjusted Firth logistic regression model for observed HIV positivity among 9961 medium- and high-risk men who have sex with men (MSM), Easy Test Know online HIV self-testing platform, China, November 2023 to February 2025.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Variables</td><td align="left" valign="bottom">&#x03B2; coefficient<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup></td><td align="left" valign="bottom">OR<sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup> (95% CI<bold>)</bold></td><td align="left" valign="bottom"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="4">Intercept</td></tr><tr><td align="left" valign="top">&#x2003;Constant</td><td align="left" valign="top">1.821960</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup></td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top" colspan="4">Age (y)</td></tr><tr><td align="left" valign="top">&#x2003;&#x003C;20</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference<sup><xref ref-type="table-fn" rid="table3fn4">d</xref></sup></td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;20&#x2010;29</td><td align="left" valign="top">1.359521</td><td align="left" valign="top">3.89 (0.52&#x2010;498.88)</td><td align="left" valign="top">.24</td></tr><tr><td align="left" valign="top">&#x2003;30&#x2010;39</td><td align="left" valign="top">0.759321</td><td align="left" valign="top">2.14 (0.30&#x2010;271.54)</td><td align="left" valign="top">.55</td></tr><tr><td align="left" valign="top">&#x2003;40&#x2010;49</td><td align="left" valign="top">1.410274</td><td align="left" valign="top">4.10 (0.50&#x2010;531.29)</td><td align="left" valign="top">.23</td></tr><tr><td align="left" valign="top">&#x2003;50&#x2010;59</td><td align="left" valign="top">0.422914</td><td align="left" valign="top">1.53 (0.004&#x2010;320.85)</td><td align="left" valign="top">.85</td></tr><tr><td align="left" valign="top">&#x2003;&#x2265;60</td><td align="left" valign="top">0.809970</td><td align="left" valign="top">2.25 (0.01&#x2010;417.79)</td><td align="left" valign="top">.69</td></tr><tr><td align="left" valign="top" colspan="4">Sexual orientation</td></tr><tr><td align="left" valign="top">&#x2003;Uncertain</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Bisexual</td><td align="left" valign="top">&#x2013;5.441295</td><td align="left" valign="top">0.004 (0.000&#x2010;1.38)</td><td align="left" valign="top">.06</td></tr><tr><td align="left" valign="top">&#x2003;Gay</td><td align="left" valign="top">&#x2013;4.581704</td><td align="left" valign="top">0.01 (0.000&#x2010;1.82)</td><td align="left" valign="top">.07</td></tr><tr><td align="left" valign="top" colspan="4">High-risk venue category</td></tr><tr><td align="left" valign="top">&#x2003;0 types</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;1 type</td><td align="left" valign="top">&#x2013;3.907189</td><td align="left" valign="top">0.02 (0.001&#x2010;5.29)</td><td align="left" valign="top">.13</td></tr><tr><td align="left" valign="top">&#x2003;&#x2265;2 types</td><td align="left" valign="top">&#x2013;2.969411</td><td align="left" valign="top">0.05 (0.002&#x2010;13.01)</td><td align="left" valign="top">.23</td></tr><tr><td align="left" valign="top" colspan="4">Condom use</td></tr><tr><td align="left" valign="top">&#x2003;Consistent use</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Occasional use</td><td align="left" valign="top">3.677832</td><td align="left" valign="top">39.56 (1.18&#x2010;14,271.82)</td><td align="left" valign="top">.04</td></tr><tr><td align="left" valign="top">&#x2003;No use</td><td align="left" valign="top">4.218966</td><td align="left" valign="top">67.96 (1.88&#x2010;25,170.82)</td><td align="left" valign="top">.02</td></tr><tr><td align="left" valign="top" colspan="4">HIV-positive partner</td></tr><tr><td align="left" valign="top">&#x2003;Uncertain</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">1.881925</td><td align="left" valign="top">6.57 (2.87&#x2010;13.58)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">5.148746</td><td align="left" valign="top">172.22 (7.76&#x2010;27,046.77)</td><td align="left" valign="top">.002</td></tr><tr><td align="left" valign="top" colspan="4">Number of partners</td></tr><tr><td align="left" valign="top">&#x2003;&#x003E;10</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;2&#x2010;5</td><td align="left" valign="top">&#x2013;4.740278</td><td align="left" valign="top">0.009 (0.002&#x2010;0.05)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top">&#x2003;6&#x2010;9</td><td align="left" valign="top">&#x2013;4.334894</td><td align="left" valign="top">0.01 (0.002&#x2010;0.08)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top" colspan="4">Commercial sex</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">&#x2013;0.289085</td><td align="left" valign="top">0.75 (0.11&#x2010;3.21)</td><td align="left" valign="top">.72</td></tr><tr><td align="left" valign="top" colspan="4">STI<sup><xref ref-type="table-fn" rid="table3fn5">e</xref></sup> history</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">4.641172</td><td align="left" valign="top">103.67 (7.77&#x2010;14,296.85)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top" colspan="4">New psychoactive drug use</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">0.144633</td><td align="left" valign="top">1.16 (0.55&#x2010;2.79)</td><td align="left" valign="top">.72</td></tr><tr><td align="left" valign="top" colspan="4">Sexual role</td></tr><tr><td align="left" valign="top">&#x2003;Both insertive and receptive</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Receptive</td><td align="left" valign="top">0.081073</td><td align="left" valign="top">1.08 (0.48&#x2010;2.81)</td><td align="left" valign="top">.85</td></tr><tr><td align="left" valign="top">&#x2003;Insertive</td><td align="left" valign="top">&#x2013;0.269181</td><td align="left" valign="top">0.76 (0.33&#x2010;2.03)</td><td align="left" valign="top">.57</td></tr><tr><td align="left" valign="top" colspan="4">Group sex</td></tr><tr><td align="left" valign="top">&#x2003;Uncertain</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.559976</td><td align="left" valign="top">1.75 (0.25&#x2010;222.00)</td><td align="left" valign="top">.67</td></tr><tr><td align="left" valign="top">&#x2003;Occasional</td><td align="left" valign="top">1.135768</td><td align="left" valign="top">3.11 (0.35&#x2010;410.44)</td><td align="left" valign="top">.37</td></tr><tr><td align="left" valign="top" colspan="4">PEP<sup><xref ref-type="table-fn" rid="table3fn6">f</xref></sup> use</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">4.579115</td><td align="left" valign="top">97.43 (0.45&#x2010;21,356.33)</td><td align="left" valign="top">.08</td></tr><tr><td align="left" valign="top" colspan="4">PrEP<sup><xref ref-type="table-fn" rid="table3fn7">g</xref></sup> use</td></tr><tr><td align="left" valign="top">&#x2003;No</td><td align="left" valign="top">0.000000</td><td align="left" valign="top">Reference</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">&#x2003;Yes</td><td align="left" valign="top">&#x2013;2.328992</td><td align="left" valign="top">0.10 (0.001&#x2010;0.68)</td><td align="left" valign="top">.01</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>&#x03B2; coefficients are on the log-odds scale.</p></fn><fn id="table3fn2"><p><sup>b</sup>OR: odds ratio.</p></fn><fn id="table3fn3"><p><sup>c</sup>Not applicable.</p></fn><fn id="table3fn4"><p><sup>d</sup>Categorical predictors use indicator coding, with the category labeled &#x201C;Reference&#x201D; as the reference level.</p></fn><fn id="table3fn5"><p><sup>e</sup>STI: sexually transmitted infection.</p></fn><fn id="table3fn6"><p><sup>f</sup>PEP: postexposure prophylaxis.</p></fn><fn id="table3fn7"><p><sup>g</sup>PrEP: pre-exposure prophylaxis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Model Comparison and Optimization</title><sec id="s3-2-1"><title>Model Discriminatory Ability</title><p>The enhanced behavioral model achieved an apparent AUC of 0.728 (95% CI 0.656&#x2010;0.801; Table S1 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>), compared with 0.646 (95% CI 0.567&#x2010;0.725) for the continuous platform score, corresponding to a &#x0394;AUC of +0.082. The DeLong test indicated significantly better apparent discrimination for the enhanced model (<italic>P</italic>=.01; Table S2 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>).</p><p>The fully adjusted Firth model achieved the highest apparent AUC of 0.752 (95% CI 0.686&#x2010;0.817; Table S1 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>) and also significantly outperformed the continuous platform score by DeLong test (<italic>P</italic>&#x003C;.001; Table S2 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>).</p><p>Bootstrap internal validation identified mean AUC optimism of 0.040 for the enhanced behavioral model and 0.039 for the fully adjusted Firth model, yielding optimism-corrected AUCs of 0.688 and 0.713, respectively (Table S1 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). The continuous platform score and deployed categorical output were fixed platform measures rather than models estimated in this dataset and therefore were not optimism-corrected.</p><p>The fitted intercepts were 1.972304 for the enhanced model and 1.821960 for the fully adjusted model. <xref ref-type="table" rid="table3">Table 3</xref> and Table S5 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref> provide the exact log-odds coefficients and complete specifications for the fully adjusted and enhanced behavioral models, respectively. To calculate an individual predicted probability, code each categorical predictor using the reference category listed in the corresponding table, calculate the linear predictor, &#x03B7; = &#x03B2;<sub>0</sub> + &#x03A3;&#x03B2;<sub>j</sub>X<sub>j</sub>, and transform it as <italic>P</italic> = exp(&#x03B7;)/[1 + exp(&#x03B7;)]. These equations describe model use for prediction; they do not establish a clinical decision threshold.</p><p>Receiver operating characteristic analyses (<xref ref-type="fig" rid="figure1">Figure 1</xref>) showed that the reconstructed behavioral models improved discrimination compared with the continuous platform score, whereas the deployed categorical output emphasized sensitivity (54/58, 93.1%) over specificity (913/9903, 9.2%). The continuous platform score was retained as the primary baseline for model comparison because it preserves the information used by the platform before categorization.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Receiver operating characteristic curves for adjusted models vs platform model among 9961 medium- and high-risk men who have sex with men, Easy Test Know online HIV self-testing platform, China, November 2023 to February 2025. AUC: area under the receiver operating characteristic curve.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e104883_fig01.png"/></fig></sec><sec id="s3-2-2"><title>Model Calibration Performance</title><p>Both reconstructed models showed favorable apparent calibration in the development data (Table S3 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). The enhanced behavioral model had a calibration-in-the-large of &#x2013;0.149, a calibration slope of 1.031, an E/O ratio of 1.144, a Brier score of 0.005102, and a Hosmer-Lemeshow <italic>&#x03C7;</italic><sup>2</sup><sub>7</sub>=7.007 (<italic>P</italic>=.43). Corresponding values for the fully adjusted Firth model were &#x2013;0.162, 1.035, 1.158, 0.005103, and <italic>&#x03C7;</italic><sup>2</sup><sub>8</sub>=7.121 (<italic>P</italic>=.52).</p><p>After bootstrap optimism correction, the enhanced model had a calibration-in-the-large of &#x2013;0.141, a calibration slope of 0.940, an E/O ratio of 1.137, and a Brier score of 0.005273. Corresponding corrected values for the fully adjusted model were &#x2013;0.152, 0.936, 1.149, and 0.005292 (Table S3 in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). Together, these findings suggest that the reconstructed models largely retained favorable calibration after adjustment for optimism. The calibration plots additionally display apparent and bootstrap bias-corrected curves based on 1000 resamples (<xref ref-type="fig" rid="figure2">Figure 2</xref>).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Calibration curves for adjusted models vs platform model among 9961 medium- and high-risk men who have sex with men, Easy Test Know online HIV self-testing platform, China, November 2023 to February 2025. CL: confidence limits.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e104883_fig02.png"/></fig><p>The enhanced behavioral model included 22 predictor parameters for 58 HIV-positive events (2.64 events per parameter), and the fully adjusted model included 24 predictor parameters (2.42 events per parameter). Because several predictor categories were sparsely populated, obtaining 1000 successful bootstrap refits required 2623 attempts for the enhanced model and 2944 attempts for the fully adjusted model. The prespecified target of 1000 successful refits was achieved for both models. Although optimism correction appropriately produced more conservative estimates, the fully adjusted model retained the highest AUC, and both reconstructed models maintained calibration slopes close to 1. Thus, the internally validated results preserved the overall performance advantage of the reconstructed models, although external validation in larger datasets is needed to confirm and further refine these estimates.</p></sec></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This study evaluated the performance of a digital HIV behavioral risk stratification system integrated with online HIVST services among MSM with available test results in the medium- and high-risk pathways. The deployed categorical output showed high sensitivity but low specificity, whereas the continuous platform score provided modest discrimination. Outcome-driven behavioral models achieved higher apparent AUCs and retained improved AUCs after bootstrap optimism correction, and high-risk venue diversity was associated with observed HIV positivity. The relatively low observed positivity proportion (58/9961, 0.58%) may partly reflect the platform&#x2019;s broad, prevention-oriented case-finding strategy, which prioritized sensitivity (54/58, 93.1%) over specificity (913/9903, 9.2%) and therefore included many HIV-negative users rather than restricting testing to a narrowly selected clinical population. These findings address the study aims but apply only to the analyzed population and should not be interpreted as population prevalence or performance across the full risk spectrum.</p><p>The categorical and continuous platform results require separate interpretation. Positivity was 0.6% (54/58) in the high-risk group and 0.4% (4/914) in the medium-risk group, but the difference was not statistically significant. This nonsignificant difference between categories does not establish that the platform lacks practical value; rather, it supports evaluating and refining its thresholds using observed outcome data.</p><p>The observed association between exposure to multiple high-risk venues and HIV positivity suggests that cumulative venue-based behavioral exposure may provide additional information beyond conventional individual behavioral indicators. These findings support the potential value of integrating multidimensional behavioral exposure measures into digital HIV risk assessment frameworks.</p></sec><sec id="s4-2"><title>Potential Mechanism for the High-Risk Venue Diversity Score</title><p>The association between high-risk venue diversity score and HIV positivity may reflect broader patterns of cumulative behavioral exposure. On the one hand, different types of high-risk sites may offer greater anonymity, more frequent temporary partner contacts, and environments where continuous risk prevention is difficult to maintain. Exposure to multiple sites often places individuals in more complex and overlapping high-risk sexual networks. On the other hand, the number of different sites individuals visit may reflect several risk dimensions, such as the frequency of behaviors, sexual behavior diversity, and the degree of social network overlap. Compared with a single behavioral indicator, this metric provides a more comprehensive reflection of cumulative risk intensity, which may help explain the dose-response relationship for HIV positivity [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref>]. Because these mechanisms were not measured directly, the venue diversity finding should be interpreted as predictive rather than causal. Nevertheless, it suggests that venue-based exposure measures may contribute additional information to digital HIV risk assessment beyond conventional single-behavior indicators [<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>].</p></sec><sec id="s4-3"><title>Interpretation of Drug Use Findings</title><p>Although drug use was more common among participants classified as high risk by the platform algorithm, it was not significantly associated with observed HIV positivity. The questionnaire item combined new psychoactive drugs but did not capture specific substances, frequency, dose, or recency. Accordingly, the high reported proportion should not be generalized to the broader MSM population, and the null association may reflect limited measurement specificity or statistical power rather than the absence of a relationship with HIV risk.</p><p>One possible explanation is that drug use may reflect the clustering of multiple co-occurring high-risk behaviors within the platform&#x2019;s scoring framework. However, after adjustment for other behavioral factors, its additional predictive contribution appeared limited. These findings suggest that the relative importance of specific behavioral indicators may differ between expert-defined scoring systems and data-driven predictive models.</p></sec><sec id="s4-4"><title>Comparison With Existing Studies</title><p>Compared with many previous studies focusing on individual behavioral factors or offline testing populations [<xref ref-type="bibr" rid="ref22">22</xref>], the present study evaluated behavioral risk prediction within a real-world online HIVST platform. The observed association between exposure to multiple high-risk venues and HIV positivity is broadly consistent with previous studies suggesting that repeated exposure across diverse sexual or social environments may be associated with increased HIV risk.</p><p>In addition, the use of real-world platform-based behavioral and transaction data provides insight into HIVST users who may be less engaged with conventional in-person testing services. Recent digitally supported HIVST programs have also shown that online self-testing can be connected to counseling, prevention, and linkage to care [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>]. The present study complements this literature by evaluating the correspondence between a prepurchase behavioral assessment and available testing outcomes.</p></sec><sec id="s4-5"><title>Implications of Digital Risk Stratification</title><p>Importantly, the improved performance observed in the reconstructed behavioral models should not be interpreted simply as the addition of entirely new predictors. Several behavioral variables included in the optimized models were already incorporated into the platform&#x2019;s original rule-based scoring system. Rather, the observed improvement likely reflects differences in how behavioral information was aggregated and weighted. The platform algorithm relies on predefined, expert-assigned weights, whereas the present study applied a data-driven regression framework to estimate the relative contributions of behavioral variables directly from observed outcome data. These findings suggest that optimizing weighting strategies and behavioral feature integration may substantially improve the predictive performance of digital HIV risk stratification tools. It should be noted that the comparison is between a model optimized on the current dataset and a fixed algorithm; the observed improvement partly reflects the statistical advantage of in-sample optimization and does not imply that the platform algorithm is deficient.</p><p>From an application standpoint, the reconstructed behavioral models demonstrated improved discrimination compared with the continuous platform score, and the fully adjusted model retained the highest AUC after bootstrap optimism correction (0.713). The optimism-corrected calibration slopes also remained close to 1, supporting the potential value of integrating multidimensional behavioral indicators and outcome-informed weighting into digital HIV risk stratification. These models may provide a useful foundation for refining risk assessment and identifying individuals who could benefit from prioritized follow-up testing, online counseling, self-test support, or linkage to PrEP and other prevention services, particularly in resource-limited settings [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref>]. In a national-level implementation study in Vietnam [<xref ref-type="bibr" rid="ref9">9</xref>], an online HIVST distribution program successfully linked 97.5% of individuals with reactive results to treatment, while approximately 20% of those with negative results initiated or continued PrEP. This experience further illustrates how appropriately validated digital risk assessment tools could be integrated into the HIV detection, prevention, and treatment continuum. Further external validation of the present models would help confirm their performance and inform appropriate implementation thresholds.</p></sec><sec id="s4-6"><title>Limitations</title><p>This study has several limitations. First, outcome ascertainment depended on a usable self-test result returned through the platform or an offline result reported after assessment. Participants without usable returned results were excluded rather than classified as HIV-negative, but selective result reporting may still affect the observed positivity proportion and model coefficients. The findings should therefore not be interpreted as HIV prevalence among all purchasers or the broader MSM population.</p><p>Second, low-risk users were not represented because they generally did not proceed through the same purchase and result-return pathway. Restricting the analysis to medium- and high-risk participants compressed the evaluated score range; consequently, the reported platform performance applies only to the observed risk spectrum and not to all platform users.</p><p>Third, only 58 HIV-positive outcomes were available, and the fully adjusted model included 24 predictor parameters, corresponding to 2.42 events per parameter. Firth penalization reduced coefficient bias and provided finite estimates under separation, but it did not eliminate overfitting. Bootstrap internal validation yielded more conservative AUC estimates, while the corrected calibration slopes remained close to 1; however, the limited number of events and sparse predictor categories affected the stability of bootstrap refitting. Independent validation is therefore needed to confirm the observed performance gains.</p><p>Finally, the behavioral data were self-reported and may have been affected by recall or social desirability bias. Several questionnaire items were broad or sparsely populated, and the observational design does not support causal interpretation of the reported associations.</p></sec><sec id="s4-7"><title>Future Research Directions</title><p>Future research should externally validate the continuous score, deployed categories, and more parsimonious outcome-driven models in larger independent cohorts that include the full risk spectrum and more complete outcome ascertainment. Temporal or geographic validation and assessment of alternative thresholds would help determine whether the optimism-corrected performance gains translate into useful service decisions.</p><p>Longitudinal studies should also examine the timing and frequency of venue exposure and incorporate partner- or network-level information. As digital HIVST interventions enter the regulatory landscape, standardized approaches to model validation, updating, privacy, and fairness will also be important [<xref ref-type="bibr" rid="ref25">25</xref>].</p></sec><sec id="s4-8"><title>Conclusions</title><p>Among MSM who entered the medium- and high-risk online HIVST pathway and had available test results, high-risk venue diversity was associated with observed HIV positivity, and outcome-driven behavioral models achieved higher apparent discrimination than the platform&#x2019;s continuous rule-based score. After bootstrap optimism correction, the fully adjusted model retained the highest AUC (0.713), and the corrected calibration slopes for both reconstructed models remained close to 1, supporting the potential value of data-driven behavioral weighting for digital HIV risk stratification. The deployed categorical output retained high sensitivity, indicating value for broad risk capture, although its low specificity suggests that the operating threshold could be refined. Taken together, these findings support the feasibility of using routinely collected behavioral and testing outcomes to iteratively evaluate and update digital risk-stratification tools. With further validation, such tools may help online HIVST programs prioritize follow-up testing, tailored counseling, prevention support, and linkage to care, complementing digitally supported HIVST service models reported previously [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>]. This study therefore provides a practical framework for optimizing rule-based digital assessment systems while preserving accessible self-testing pathways. Because low-risk users and purchasers without usable results were not represented and only 58 positive outcomes were observed, independent validation, broader outcome ascertainment, and prospective assessment of decision thresholds are needed before programmatic implementation. In practice, simply counting the number of distinct high-risk venues a user reports could serve as an easily collectible proxy to prioritize resource allocation for follow-up counseling.</p></sec></sec></body><back><notes><sec><title>Generative AI Use</title><p>ChatGPT - 5.6 (OpenAI), a generative AI tool, was used to assist with English-language editing and manuscript refinement, including improvements in grammar, clarity, and readability. This tool was not used for data analysis, interpretation of findings, or generation of scientific conclusions. All scientific content and editorial decisions were made by the authors, who take full responsibility for the accuracy, integrity, and originality of the manuscript.</p></sec><sec><title>Funding</title><p>This study was supported by the China National Science and Technology Major Project for Infectious Diseases from the Ministry of Science and Technology (grant 2018ZX10732101-001-010); the Introducing the Talented Person Scientific Research Start-Up Funds Subsidization Project of Chengdu University of Traditional Chinese Medicine (030040035); the Science and Technology Program of Beijing, China (grant D171100006717001); and HIV/AIDS prevention and control technical guidance and capacity building funds. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><sec><title>Data Availability</title><p>The datasets generated or analyzed during this study are available from the corresponding author upon reasonable request.</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization: GZ, YL</p><p>Data curation: GZ</p><p>Data analysis: WL</p><p>Investigation: YL</p><p>Methodology: WL, YL</p><p>Resources: YJ</p><p>Supervision: YJ, YL</p><p>Visualization: WL</p><p>Writing &#x2013; original draft: WL</p><p>Writing &#x2013; review &#x0026; editing: GZ, YL, YJ</p><p>WL, YJ, GZ, and YL reviewed and approved the final manuscript.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AUC</term><def><p>area under the receiver operating characteristic curve</p></def></def-item><def-item><term id="abb2">E/O</term><def><p>expected-to-observed</p></def></def-item><def-item><term id="abb3">HIVST</term><def><p>HIV self-testing</p></def></def-item><def-item><term id="abb4">MSM</term><def><p>men who have sex with men</p></def></def-item><def-item><term id="abb5">OR</term><def><p>odds ratio</p></def></def-item><def-item><term id="abb6">PEP</term><def><p>postexposure prophylaxis</p></def></def-item><def-item><term id="abb7">PrEP</term><def><p>pre-exposure prophylaxis</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beecroft</surname><given-names>A</given-names> </name><name name-style="western"><surname>Vaikla</surname><given-names>O</given-names> </name><name name-style="western"><surname>Engel</surname><given-names>N</given-names> </name><name name-style="western"><surname>Duchaine</surname><given-names>T</given-names> </name><name name-style="western"><surname>Liang</surname><given-names>C</given-names> </name><name name-style="western"><surname>Pant Pai</surname><given-names>N</given-names> </name></person-group><article-title>Evidence on digital HIV self-testing from accuracy to impact: updated systematic review</article-title><source>J Med Internet Res</source><year>2025</year><month>03</month><day>4</day><volume>27</volume><fpage>e63110</fpage><pub-id pub-id-type="doi">10.2196/63110</pub-id><pub-id pub-id-type="medline">40053740</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicely</surname><given-names>P</given-names> </name><name name-style="western"><surname>Xiang</surname><given-names>L</given-names> </name><name name-style="western"><surname>Smith-Sreen</surname><given-names>J</given-names> </name><name name-style="western"><surname>Garbern</surname><given-names>SC</given-names> </name><name name-style="western"><surname>Aluisio</surname><given-names>AR</given-names> </name></person-group><article-title>Approaches and impacts of digital health in HIV self-testing uptake &#x0026; use among populations from low- and middle-income countries: a descriptive systematic review and meta-analysis</article-title><source>J Public Health Emerg</source><year>2025</year><month>06</month><day>25</day><volume>9</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.21037/jphe-24-56</pub-id><pub-id pub-id-type="medline">41924433</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x2019;Byrne</surname><given-names>P</given-names> </name><name name-style="western"><surname>Musten</surname><given-names>A</given-names> </name><name name-style="western"><surname>Vandyk</surname><given-names>A</given-names> </name><etal/></person-group><article-title>HIV self-testing in Ottawa, Canada used by persons at risk for HIV: the GetaKit study</article-title><source>Can Commun Dis Rep</source><year>2021</year><month>10</month><day>14</day><volume>47</volume><issue>10</issue><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.14745/ccdr.v47i10a06</pub-id><pub-id pub-id-type="medline">34737676</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>MC</given-names> </name><name name-style="western"><surname>Chung</surname><given-names>R</given-names> </name><name name-style="western"><surname>Leung</surname><given-names>SYJ</given-names> </name><name name-style="western"><surname>Edelstein</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Yuan</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Flavin</surname><given-names>SM</given-names> </name></person-group><article-title>Combating stigma through HIV self-testing: new York State&#x2019;s HIV home test giveaway program for sexual minorities</article-title><source>J Public Health Manag Pract</source><year>2022</year><volume>28</volume><issue>2</issue><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1097/PHH.0000000000001138</pub-id><pub-id pub-id-type="medline">32015253</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caldwell</surname><given-names>JA</given-names> </name><name name-style="western"><surname>Dana</surname><given-names>R</given-names> </name><name name-style="western"><surname>Lucas</surname><given-names>IL</given-names> </name><etal/></person-group><article-title>Adaptation of a protocol to evaluate online recruitment strategies for mailing HIV self-tests and pilot an intervention to improve linkage to HIV prevention and care among transgender women: protocol for a randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2026</year><month>02</month><day>20</day><volume>15</volume><fpage>e75345</fpage><pub-id pub-id-type="doi">10.2196/75345</pub-id><pub-id pub-id-type="medline">41719490</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Abrahams</surname><given-names>M</given-names> </name><name name-style="western"><surname>Shankland</surname><given-names>L</given-names> </name><name name-style="western"><surname>Lalla-Edward</surname><given-names>ST</given-names> </name><name name-style="western"><surname>Edward</surname><given-names>VA</given-names> </name><name name-style="western"><surname>De Wit</surname><given-names>J</given-names> </name></person-group><article-title>The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-testing</article-title><source>Front Reprod Health</source><year>2023</year><volume>5</volume><fpage>1121478</fpage><pub-id pub-id-type="doi">10.3389/frph.2023.1121478</pub-id><pub-id pub-id-type="medline">36864847</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>PSF</given-names> </name><name name-style="western"><surname>Chidgey</surname><given-names>A</given-names> </name><name name-style="western"><surname>Lau</surname><given-names>J</given-names> </name><name name-style="western"><surname>Ip</surname><given-names>M</given-names> </name><name name-style="western"><surname>Lau</surname><given-names>JTF</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names> </name></person-group><article-title>Effectiveness of a novel HIV self-testing service with online real-time counseling support (HIVST-Online) in increasing HIV testing rate and repeated HIV testing among men who have sex with men in Hong Kong: results of a pilot implementation project</article-title><source>Int J Environ Res Public Health</source><year>2021</year><month>01</month><day>15</day><volume>18</volume><issue>2</issue><fpage>729</fpage><pub-id pub-id-type="doi">10.3390/ijerph18020729</pub-id><pub-id pub-id-type="medline">33467770</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sripanidkulchai</surname><given-names>K</given-names> </name><name name-style="western"><surname>Rungmaitree</surname><given-names>S</given-names> </name><name name-style="western"><surname>Durier</surname><given-names>Y</given-names> </name><etal/></person-group><article-title>Empowering at-risk Thai adolescents and young adults: an observational study of &#x201C;Stand By You&#x201D;-a person-centered online service model for HIV self-screening, text-based counseling and linkage to care</article-title><source>J Int AIDS Soc</source><year>2025</year><month>09</month><volume>28 Suppl 5</volume><issue>Suppl 5</issue><fpage>e70040</fpage><pub-id pub-id-type="doi">10.1002/jia2.70040</pub-id><pub-id pub-id-type="medline">41059621</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>VTT</given-names> </name><name name-style="western"><surname>Dunkley</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Son</surname><given-names>VH</given-names> </name><etal/></person-group><article-title>Investigating the effectiveness of web-based HIV self-test distribution and linkage to HIV treatment and PrEP among groups at elevated risk of HIV in Viet Nam provinces: a mixed-methods analysis of implementation from pilot to scale-up</article-title><source>J Int AIDS Soc</source><year>2024</year><month>07</month><volume>27 Suppl 1</volume><issue>Suppl 1</issue><fpage>e26264</fpage><pub-id pub-id-type="doi">10.1002/jia2.26264</pub-id><pub-id pub-id-type="medline">38965974</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names> </name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names> </name><name name-style="western"><surname>Operario</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Effects of a mobile health intervention to promote HIV self-testing with MSM in China: a randomized controlled trial</article-title><source>AIDS Behav</source><year>2019</year><month>11</month><volume>23</volume><issue>11</issue><fpage>3129</fpage><lpage>3139</lpage><pub-id pub-id-type="doi">10.1007/s10461-019-02452-5</pub-id><pub-id pub-id-type="medline">30852728</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Ren</surname><given-names>C</given-names> </name><name name-style="western"><surname>Liao</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Digital, crowdsourced, multilevel intervention to promote HIV testing among men who have sex with men: cluster randomized controlled trial</article-title><source>J Med Internet Res</source><year>2023</year><month>10</month><day>30</day><volume>25</volume><fpage>e46890</fpage><pub-id pub-id-type="doi">10.2196/46890</pub-id><pub-id pub-id-type="medline">37902831</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dirisu</surname><given-names>O</given-names> </name><name name-style="western"><surname>Sekoni</surname><given-names>A</given-names> </name><name name-style="western"><surname>Vu</surname><given-names>L</given-names> </name><etal/></person-group><article-title>&#x201C;I will welcome this one 101%, I will so embrace it&#x201D;: a qualitative exploration of the feasibility and acceptability of HIV self-testing among men who have sex with men (MSM) in Lagos, Nigeria</article-title><source>Health Educ Res</source><year>2020</year><month>12</month><day>23</day><volume>35</volume><issue>6</issue><fpage>524</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1093/her/cyaa028</pub-id><pub-id pub-id-type="medline">32879956</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>R</given-names> </name><name name-style="western"><surname>Karamouzian</surname><given-names>M</given-names> </name><name name-style="western"><surname>Salway</surname><given-names>T</given-names> </name><name name-style="western"><surname>Gilbert</surname><given-names>M</given-names> </name><name name-style="western"><surname>Shoveller</surname><given-names>J</given-names> </name></person-group><article-title>Online interventions to address HIV and other sexually transmitted and blood-borne infections among young gay, bisexual and other men who have sex with men: a systematic review</article-title><source>J Int AIDS Soc</source><year>2017</year><month>11</month><volume>20</volume><issue>3</issue><fpage>e25017</fpage><pub-id pub-id-type="doi">10.1002/jia2.25017</pub-id><pub-id pub-id-type="medline">29091340</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fieggen</surname><given-names>J</given-names> </name><name name-style="western"><surname>Smith</surname><given-names>E</given-names> </name><name name-style="western"><surname>Arora</surname><given-names>L</given-names> </name><name name-style="western"><surname>Segal</surname><given-names>B</given-names> </name></person-group><article-title>The role of machine learning in HIV risk prediction</article-title><source>Front Reprod Health</source><year>2022</year><volume>4</volume><fpage>1062387</fpage><pub-id pub-id-type="doi">10.3389/frph.2022.1062387</pub-id><pub-id pub-id-type="medline">36619681</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J</given-names> </name><name name-style="western"><surname>Li</surname><given-names>J</given-names> </name><name name-style="western"><surname>Jiang</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Application of machine learning algorithms in predicting HIV infection among men who have sex with men: model development and validation</article-title><source>Front Public Health</source><year>2022</year><volume>10</volume><fpage>967681</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2022.967681</pub-id><pub-id pub-id-type="medline">36091522</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ovalle</surname><given-names>A</given-names> </name><name name-style="western"><surname>Goldstein</surname><given-names>O</given-names> </name><name name-style="western"><surname>Kachuee</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Leveraging social media activity and machine learning for HIV and substance abuse risk assessment: development and validation study</article-title><source>J Med Internet Res</source><year>2021</year><month>04</month><day>26</day><volume>23</volume><issue>4</issue><fpage>e22042</fpage><pub-id pub-id-type="doi">10.2196/22042</pub-id><pub-id pub-id-type="medline">33900200</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>KM</given-names> </name><name name-style="western"><surname>Goodreau</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Morris</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Egocentric sexual networks of men who have sex with men in the United States: results from the ARTnet study</article-title><source>Epidemics</source><year>2020</year><month>03</month><volume>30</volume><fpage>100386</fpage><pub-id pub-id-type="doi">10.1016/j.epidem.2020.100386</pub-id><pub-id pub-id-type="medline">32004795</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tieu</surname><given-names>HV</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>TY</given-names> </name><name name-style="western"><surname>Hussen</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Sexual networks and HIV risk among Black men who have sex with men in 6 U.S. cities</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>8</issue><fpage>e0134085</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0134085</pub-id><pub-id pub-id-type="medline">26241742</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vermeer</surname><given-names>W</given-names> </name><name name-style="western"><surname>Gurkan</surname><given-names>C</given-names> </name><name name-style="western"><surname>Hjorth</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Agent-based model projections for reducing HIV infection among MSM: prevention and care pathways to end the HIV epidemic in Chicago, Illinois</article-title><source>PLoS One</source><year>2022</year><volume>17</volume><issue>10</issue><fpage>e0274288</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0274288</pub-id><pub-id pub-id-type="medline">36251657</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names> </name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names> </name><name name-style="western"><surname>Pan</surname><given-names>X</given-names> </name><etal/></person-group><article-title>Incidence of HIV infection and associated factors among men who have sex with men in Zhejiang, China: a cohort study</article-title><source>Front Public Health</source><year>2025</year><volume>13</volume><fpage>1551612</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2025.1551612</pub-id><pub-id pub-id-type="medline">40356820</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>VV</given-names> </name><name name-style="western"><surname>Masyukova</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sutton</surname><given-names>D</given-names> </name><name name-style="western"><surname>Horvath</surname><given-names>KJ</given-names> </name></person-group><article-title>Social media use and HIV-related risk behaviors in young Black and Latino gay and bi men and transgender individuals in New York City: implications for online interventions</article-title><source>J Urban Health</source><year>2016</year><month>04</month><volume>93</volume><issue>2</issue><fpage>388</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1007/s11524-016-0025-1</pub-id><pub-id pub-id-type="medline">26936854</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mshweshwe-Pakela</surname><given-names>NT</given-names> </name><name name-style="western"><surname>Mabuto</surname><given-names>T</given-names> </name><name name-style="western"><surname>Shankland</surname><given-names>L</given-names> </name><name name-style="western"><surname>Fischer</surname><given-names>A</given-names> </name><name name-style="western"><surname>Tsukudu</surname><given-names>D</given-names> </name><name name-style="western"><surname>Hoffmann</surname><given-names>CJ</given-names> </name></person-group><article-title>Digitally supported HIV self-testing increases facility-based HIV testing capacity in Ekurhuleni, South Africa</article-title><source>South Afr J HIV Med</source><year>2022</year><volume>23</volume><issue>1</issue><fpage>1352</fpage><pub-id pub-id-type="doi">10.4102/sajhivmed.v23i1.1352</pub-id><pub-id pub-id-type="medline">35923609</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelouahed</surname><given-names>M</given-names> </name><name name-style="western"><surname>Yateem</surname><given-names>D</given-names> </name><name name-style="western"><surname>Amzil</surname><given-names>C</given-names> </name><name name-style="western"><surname>Aribi</surname><given-names>I</given-names> </name><name name-style="western"><surname>Abdelwahed</surname><given-names>EH</given-names> </name><name name-style="western"><surname>Fredericks</surname><given-names>S</given-names> </name></person-group><article-title>Integrating artificial intelligence into public health education and healthcare: insights from the COVID-19 and monkeypox crises for future pandemic readiness</article-title><source>Front Educ</source><year>2025</year><volume>10</volume><fpage>1518909</fpage><pub-id pub-id-type="doi">10.3389/feduc.2025.1518909</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turb&#x00E9;</surname><given-names>V</given-names> </name><name name-style="western"><surname>Herbst</surname><given-names>C</given-names> </name><name name-style="western"><surname>Mngomezulu</surname><given-names>T</given-names> </name><etal/></person-group><article-title>Deep learning of HIV field-based rapid tests</article-title><source>Nat Med</source><year>2021</year><month>07</month><volume>27</volume><issue>7</issue><fpage>1165</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01384-9</pub-id><pub-id pub-id-type="medline">34140702</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Lalla-Edward</surname><given-names>ST</given-names> </name><name name-style="western"><surname>Edward</surname><given-names>V</given-names> </name><name name-style="western"><surname>Abrahams</surname><given-names>M</given-names> </name><name name-style="western"><surname>Shankland</surname><given-names>L</given-names> </name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names> </name></person-group><article-title>Should digital interventions for HIV self-testing be regulated with World Health Organization prequalification?</article-title><source>JMIR mHealth uHealth</source><year>2025</year><month>08</month><day>22</day><volume>13</volume><fpage>e60276</fpage><pub-id pub-id-type="doi">10.2196/60276</pub-id><pub-id pub-id-type="medline">40845310</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>HIV risk assessment questionnaire.</p><media xlink:href="jmir_v28i1e104883_app1.doc" xlink:title="DOC File, 35 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Quantitative algorithms and scoring systems for HIV risk assessment.</p><media xlink:href="jmir_v28i1e104883_app2.doc" xlink:title="DOC File, 24 KB"/></supplementary-material><supplementary-material id="app3"><label>Multimedia Appendix 3</label><p>Model performance, HIV positivity by high-risk venue diversity, and Firth logistic regression results among men who have sex with men using the Easy Test Know online HIV self-testing platform in China, November 2023 to February 2025.</p><media xlink:href="jmir_v28i1e104883_app3.doc" xlink:title="DOC File, 88 KB"/></supplementary-material></app-group></back></article>